Annual Cannabinoid Research Society Symposium on the Cannabinoids
年度大麻素研究会大麻素研讨会
基本信息
- 批准号:10461950
- 负责人:
- 金额:$ 1.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdolescenceAgonistAnxietyAreaAwardBiologyBooksBrainBudgetsCNR1 geneCNR2 geneCannabinoidsCannabisClassificationClinical TrialsCollaborationsCommunicationCopyrightCritiquesDevelopmentEducational workshopEndocannabinoidsEpidiolexFamily suidaeFosteringFunctional disorderFundingFunding AgencyGoalsGrantHealth ProfessionalHomeostasisHumanIncentivesIndividualInternationalInvestigationLearningLigandsMedicineMemoryMentorshipMissionMolecularMotorMovementNational Institute of Drug AbuseNeurobiologyOralParticipantPathologyPhysiologicalPregnancyPrivatizationProcessProgram DevelopmentPublic HealthPublishingRegulationReportingResearchResearch PersonnelRewardsRiskSR 141716AScienceScientific SocietiesScientistSeriesServicesSignal TransductionSocial FunctioningSocietiesSportsStudentsTalentsTrainingTravelUnited StatesUnited States National Institutes of HealthVulnerable PopulationsWomananandamideantagonistbasecannabinoid receptorcareercareer developmentcritical perioddesignethnic minorityimprovedinterestlecturesmarijuana usemeetingsmemberneuropsychiatric disordernext generationnovelposterspre-doctoralprogramspsychologicracial minorityreceptor functionrecruitsuccesssymposiumvolunteerweb site
项目摘要
PROJECT SUMMARY
Cannabinoid signaling is composed of Cannabinoid receptors CB1 and CB2 and their cognate exogenous
and endogenous ligands. Cannabinoid signaling is widely distributed throughout the CNS and periphery
and is implicated in a wide variety of important neurobiological processes including regulation of energy
homeostasis, learning and memory, motor function, reward, anxiety, and social function. Moreover, use of
cannabis has increases over the past decade and is expected to continue to increase in the face of the
expanding anti-prohibition movement in the United States. Cannabis use by vulnerable populations and
during critical periods, such as adolescence and pregnancy, carry unclear risk and are the focus of intense
ongoing scientific investigation. Commensurate with these growing potential public health concerns,
research into the fundamental biology of cannabinoids and endogenous cannabinoids related to brain
development, function, and pathology are becoming of greater interest to the public, policymakers,
researchers and healthcare professionals. Therefore, understanding the neurobiology of cannabinoid
signaling could have broad implications for physiological function and the pathophysiology of somatic and
neuropsychiatric disorders. The International Cannabinoid Research Society (ICRS) is the only annual
scientific meeting devoted to dissemination of scientific information on all aspects of cannabinoid sciences.
The ICRS will hold its 31st annual symposium in 2021 and has been an unparalleled success in the field of
cannabinoid research. During the previous funding cycle, NIH support has allowed the ICRS to provide
substantial travel support to increase trainee attendance at our annual meeting. The student travel grant
program will be used to increase the participation of early stage cannabinoid researchers in the ICRS
Symposia on the Cannabinoids. Special emphasis has been, and will continue to be, placed on support for
individuals traditionally underrepresented in science, including women and U.S. racial and ethnic
minorities. In addition to the travel award program, we propose to provide a career development program
at each annual ICRS symposium, recognize outstanding predoctoral and postdoctoral student
presentations with awards given during each symposium, and publish an abstract book in printed form that
will be made available to the public on the ICRS website after the annual symposium. Completion of these
aims will continue to invigorate the next generation of cannabinoid scientists by facilitating attendance and
presentation of their original research in an open, inclusive, and egalitarian forum and provide networking
and mentorship opportunities to young scientists in all areas of cannabinoid research.
项目总结
大麻素信号通路由大麻素受体CB1和CB2及其同源外源受体组成
和内源性配体。大麻素信号广泛分布于中枢和外周
它与多种重要的神经生物学过程有关,包括能量调节
动态平衡、学习和记忆、运动功能、奖励、焦虑和社会功能。此外,使用
大麻在过去十年中有所增加,预计将继续增加,面对
在美国扩大反禁酒令运动。易受伤害人群和
在关键时期,如青春期和妊娠期,风险不明确,是紧张的焦点
正在进行的科学调查。与这些日益增长的潜在公共卫生问题相称,
大麻素及其与脑相关的内源性大麻素的基础生物学研究
发展、功能和病理越来越受到公众、政策制定者、
研究人员和医疗保健专业人员。因此,了解大麻素的神经生物学
信号可能对生理功能和体细胞和细胞的病理生理学有广泛的影响
神经精神障碍。国际大麻素研究会(ICRS)是唯一的年度
致力于传播有关大麻类科学各方面的科学信息的科学会议。
ICRS将于2021年举行第31届年度研讨会,在这一领域取得了前所未有的成功
大麻素研究。在上一个供资周期中,国家卫生研究院的支持使ICRS能够提供
提供大量差旅支持,以增加学员出席我们年度会议的人数。学生车船津贴
将利用该方案增加早期大麻研究人员对ICRS的参与
关于大麻素的研讨会。一直并将继续特别强调支持
在科学界传统上代表性不足的个人,包括女性和美国种族和民族
少数族裔。除了旅游奖励计划外,我们还建议提供一个职业发展计划
在每次ICRS年度研讨会上,表彰优秀的博士后和博士后
在每次研讨会期间发表演讲并颁发奖项,并出版一本印刷形式的摘要书,
将在年度专题讨论会结束后在ICRS网站上向公众公布。完成这些工作
AIMS将继续通过促进出席和
在开放、包容和平等的论坛上展示他们的原创研究,并提供网络
并在大麻类药物研究的所有领域为年轻科学家提供指导机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heather Bryte Bradshaw其他文献
Heather Bryte Bradshaw的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heather Bryte Bradshaw', 18)}}的其他基金
Annual Cannabinoid Research Society Symposium on the Cannabinoids
年度大麻素研究会大麻素研讨会
- 批准号:
10672437 - 财政年份:2021
- 资助金额:
$ 1.25万 - 项目类别:
Microglial activation by N-arachidonoyl glycine
N-花生四烯酰甘氨酸激活小胶质细胞
- 批准号:
8190925 - 财政年份:2011
- 资助金额:
$ 1.25万 - 项目类别:
Microglial activation by N-arachidonoyl glycine
N-花生四烯酰甘氨酸激活小胶质细胞
- 批准号:
8306754 - 财政年份:2011
- 资助金额:
$ 1.25万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 1.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 1.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 1.25万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 1.25万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 1.25万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 1.25万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 1.25万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 1.25万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 1.25万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 1.25万 - 项目类别: